References
- Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950: 1: 3
- Goldfarb JM, Little AB. Abnormal vaginal bleeding. N Engl J Med 1980: 302(12): 666–9
- Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 3d ed. Baltimore: Williams & Wilkins. 1983: 185–200, 476–7
- Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983: 61(4): 403–7
- Hsueh AJ, Peck EJ Jr, Clark JH. Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth. Nature 1975: 254(5498): 337–9
- Gambrell RD Jr, Massey FM, Castaneda TA, et al. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens. J Am Geriatr Soc 1979: 27(9): 389–94
- Simpson JL. Disorders of sexual differentiation: etiology and clinical delineation. Orlando. FL: Academic Press, 1976: 170–4
- Paterson ME, Wade-Evans T. Sturdee DW, et al. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980: 280(6217): 822–4
- DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding: a double-blind randomized control study. Obstet Gynecol 1982: 59(3): 285–91